SPONSORED CONTENT
In the dynamic world of 340B, identifying and resolving noncompliance issues can be a time-consuming task. Stakeholders can streamline, simplify, and strengthen their 340B operations with solutions from Apexus, which brings together a wealth of knowledge, from credentialing to noncompliance resolution, to help manage a smooth and successful 340B program. Since
…
A federal district judge has accepted a plan that might speed up a decision in the drug industry’s lawsuit challenging an Arkansas law that requires drug makers to honor 340B contract pharmacy arrangements.
U.S. Senior District Judge Billy Roy Wilson
…
The U.S. government and drug makers Novartis and United Therapeutics’ cross-appeals in their 340B contract pharmacy legal dispute have been set for oral arguments in October, marking the first of the closely watched lawsuits to advance to oral arguments at
…
Q: Where did you grow up?
Pittsburgh, Pennsylvania. As my team knows, I love to spot fellow ‘burgh natives in the field.
Q: Where did you go to college/graduate school?
I received my undergraduate degree from University of Michigan Honors College and my PharmD from University of Michigan. I did my postdoc fellowship with Northeastern and
…
The federal government during the past week filed responses to arguments that drug manufacturers AstraZeneca and Lilly made in federal appeals courts in their 340B contract pharmacy lawsuits.
“In enacting the 340B program, Congress was clear that drug manufacturers must
…
Medicare Part D beneficiaries were much less likely to use lower-cost, authorized generic versions of highly expensive hepatitis C drugs Harvoni and Epclusa in 2019 and 2020 than Medicaid beneficiaries, driving up costs for Part D enrollees and the Medicare
…
Total sales in the 340B drug pricing program reached $43.9 billion in 2021, a 15.6% increase over 2020 sales and more than 3.5 times above total sales in 2015 ($12.1 billion), according to federal data obtained by Drug Channels Institute
…
The Government Accountability Office (GAO), Congress’s watchdog agency, is conducting a study of a new law that enables hospitals to maintain or regain their 340B eligibility despite having fallen below the minimum required Medicare disproportionate share (DSH) adjustment percentage due
…
Community health center advocates have strongly criticized a new Kaiser Health News (KHN) investigative report that found that some health centers have large profit margins.
The article found that nine of the nation’s nearly 1,400 health centers reported profit margins
…
President Joe Biden this afternoon is scheduled to sign legislation that for the first time will let Medicare negotiate the prices of certain costly prescription drugs and require drug makers to pay Medicare rebates when their prices outpace inflation.
House
…
×
*Sign up for news summaries and alerts from 340B Report
